Timed inhibition of the renin-angiotensin system suppresses the rise in blood pressure upon awakening in spontaneously hypertensive rats.

[1]  A. Danser,et al.  Prorenin, renin, angiotensinogen, and angiotensin-converting enzyme in normal and failing human hearts. Evidence for renin binding. , 1997, Circulation.

[2]  B. Janssen,et al.  Circadian and ultradian control of cardiac output in spontaneous hypertension in rats. , 1997, The American journal of physiology.

[3]  E. Jones,et al.  The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night , 1997, Journal of hypertension.

[4]  M. Alderman,et al.  Novel delivery system for verapamil designed to achieve maximal blood pressure control during the early morning. , 1996, American heart journal.

[5]  G. V. van Montfrans,et al.  Effects of antihypertensive drugs on the circadian blood pressure profile. , 1996, Journal of cardiovascular pharmacology.

[6]  H. Black,et al.  Once-daily monotherapy with trandolapril in the treatment of hypertension. , 1996, Journal of human hypertension.

[7]  B. Lemmer,et al.  Effects of the Angiotensin II Receptor Antagonist Losartan on 24‐Hour Blood Pressure Profiles of Primary and Secondary Hypertensive Rats , 1995, Journal of cardiovascular pharmacology.

[8]  K H Wesseling,et al.  Circadian profile of systemic hemodynamics. , 1995, Hypertension.

[9]  Lipicky Rj,et al.  Trough: peak ratio the rationale behind the United States Food and Drug Administration recommendations , 1994, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[10]  H. S. Struijker Boudier,et al.  Diurnal variation in prorenin in relation to other humoral factors and hemodynamics. , 1994, American journal of hypertension.

[11]  D. Ganten,et al.  Effects of Enalaprilat on Circadian Profiles in Blood Pressure and Heart Rate of Spontaneously and Transgenic Hypertensive Rats , 1994, Journal of cardiovascular pharmacology.

[12]  B. Janssen,et al.  Time-dependent efficacy of antihypertensive agents in spontaneously hypertensive rats. , 1993, Chronobiology international.

[13]  B. Lemmer,et al.  Chronobiologic evaluation of angiotensin-converting enzyme activity in serum and lung tissue from normotensive and spontaneously hypertensive rats. , 1993, Chronobiology international.

[14]  B. Lemmer,et al.  Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration , 1993, Clinical pharmacology and therapeutics.

[15]  P. Palatini,et al.  Effect of evening versus morning benazepril on 24-hour blood pressure: a comparative study with continuous intraarterial monitoring. , 1993, International journal of clinical pharmacology, therapy, and toxicology.

[16]  S. Gardiner,et al.  Comparison of the regional haemodynamic effects of the AT1‐receptor antagonists, losartan and EXP 3174, in water‐deprived Brattleboro rats , 1993, British journal of pharmacology.

[17]  P. Palatini,et al.  Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril , 1992, Clinical pharmacology and therapeutics.

[18]  R. Armstrong,et al.  Distribution of cardiac output during diurnal changes of activity in rats. , 1991, The American journal of physiology.

[19]  B. Materson,et al.  Classic therapeutic trials in hypertension. Were patients vulnerable to unsuppressed peak morning blood pressure? , 1991, American journal of hypertension.

[20]  B. Janssen,et al.  Modification of Circadian Blood Pressure and Heart Rate Variability by Five Different Antihypertensive Agents in Spontaneously Hypertensive Rats , 1991, Journal of cardiovascular pharmacology.

[21]  T. Unger,et al.  Inhibition of converting enzyme in the cerebrospinal fluid of rats after oral treatment with converting enzyme inhibitors. , 1989, The Journal of pharmacology and experimental therapeutics.

[22]  Daniel B Hier,et al.  Morning increase in onset of ischemic stroke. , 1989, Stroke.

[23]  P. Stone,et al.  Circadian variation and triggers of onset of acute cardiovascular disease. , 1989, Circulation.

[24]  D. Pe.  [Angiotensin-converting enzyme inhibitors]. , 1988 .

[25]  G Parati,et al.  Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. , 1987, Journal of hypertension.

[26]  B. E. Watkins,et al.  Circadian Changes in Plasma Renin Activity and Plasma Aldosterone Concentrationin Two‐Kidney Hypertensive Rats , 1979, Hypertension.

[27]  M. Gutkin,et al.  The circadian rhythm of renin. , 1976, The Journal of clinical endocrinology and metabolism.

[28]  O. Jolobe.  Angiotensin-converting enzyme inhibitors. , 1995, British journal of hospital medicine.

[29]  P. Meredith,et al.  FDA Guidelines on Trough: Peak Ratios in the Evaluation of Antihypertensive Agents , 1994, Journal of cardiovascular pharmacology.

[30]  B. Gould,et al.  Twenty-four-hour blood pressure control: an intraarterial review. , 1991, Chronobiology international.

[31]  W. Kirch,et al.  Angiotensin-converting enzyme inhibitors. Relationship between pharmacodynamics and pharmacokinetics. , 1988, Clinical pharmacokinetics.